These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 65494)

  • 41. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 42. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 44. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 45. [A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)].
    Xiao XL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Aug; 4(4):224-5. PubMed ID: 6804194
    [No Abstract]   [Full Text] [Related]  

  • 46. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.
    Fu LM; Shinnick TM
    J Infect; 2007 Mar; 54(3):277-84. PubMed ID: 16822547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Isolation of tubercle bacilli resistant to kanamycin or viomycine from tuberculous patients].
    Endo K; Takahashi M; Hashimoto H; Mitsuhashi S
    J Antibiot B; 1967 Aug; 20(4):251-3. PubMed ID: 4295238
    [No Abstract]   [Full Text] [Related]  

  • 48. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II].
    Afanas'eva IuP; Dorozhkova IR
    Lab Delo; 1969; 5():296-8. PubMed ID: 4185263
    [No Abstract]   [Full Text] [Related]  

  • 49. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action and resistance mechanisms of capreomycin: a functional genomic perspective].
    Liu XM; Xie JP
    Yao Xue Xue Bao; 2008 Aug; 43(8):788-92. PubMed ID: 18956769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-resistant tuberculosis.
    Iseman MD; Madsen LA
    Clin Chest Med; 1989 Sep; 10(3):341-53. PubMed ID: 2505962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on the resistance of tubercle bacilli to kanamycin. 4. In vivo studies on the cross resistance of tubercle bacilli to kanamycin, fradiomycin and viomycin].
    MAEDA T
    Kekkaku; 1960 Apr; 35():237-41. PubMed ID: 14419711
    [No Abstract]   [Full Text] [Related]  

  • 57. [The susceptibility of in vitro-selected drug-resistant strains of M. tuberculosis to lysis by mycobacteriophage PH (MTPH 9), and the study of a lysogenic mutant isolated from the SM-resistant strain (author's transl)].
    Sushida K; Yayoshi M; Nakano H; Kono M; Wakai M
    Kekkaku; 1981 Dec; 56(12):561-6. PubMed ID: 6799688
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies on the resistance of tubercle bacilli to kanamycin. 3. In vitro experiments on the cross resistance of tubercle bacilli to kanamycin, fradiomycin and viomycin].
    MAEDA T
    Kekkaku; 1960 Mar; 35():159-62. PubMed ID: 14419710
    [No Abstract]   [Full Text] [Related]  

  • 59. Status of drug resistance of mycobacterium tuberculosis strains isolated from hospitalized patients in Lucknow.
    Agrawal SK; Khan AM; Tewari L; Srivastava VK; Rai OP; Mehrotra RM
    Indian J Public Health; 1979; 23(1):24-8. PubMed ID: 112054
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections.
    Oliva B; Comanducci A; Chopra I
    Tuber Lung Dis; 1998; 79(2):107-9. PubMed ID: 10645448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.